{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:55:23Z","timestamp":1792292123855,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2014\/50928-2"],"award-info":[{"award-number":["#2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2017\/04335"],"award-info":[{"award-number":["#2017\/04335"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#465687\/2014-8"],"award-info":[{"award-number":["#465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13346-024-01692-w","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:02:59Z","timestamp":1725274979000},"page":"753-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies"],"prefix":"10.1007","volume":"15","author":[{"given":"Juliana Santos Rosa","family":"Viegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackeline Souza","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Nani","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Garcia","family":"Pra\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Orestes Del","family":"Ciampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enilza Maria","family":"Espre\u00e1fico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Andrey Cipriani","family":"Frade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1246-5433","authenticated-orcid":false,"given":"Maria Vit\u00f3ria Lopes Badra","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"1692_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.addr.2020.02.005","volume":"153","author":"LN Borgheti-Cardoso","year":"2020","unstructured":"Borgheti-Cardoso LN, et al. Nanotechnology approaches in the current therapy of skin cancer. Adv Drug Deliv Rev. 2020;153:109\u201336. https:\/\/doi.org\/10.1016\/j.addr.2020.02.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"1692_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva A, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542:115\u20138. https:\/\/doi.org\/10.1038\/nature21056.","journal-title":"Nature"},{"key":"1692_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2016.03.010","volume":"228","author":"M Dorrani","year":"2016","unstructured":"Dorrani M, et al. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J Control Release. 2016;228:150\u20138. https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.010.","journal-title":"J Control Release"},{"key":"1692_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41598-018-19463-2","volume":"8","author":"J Pan","year":"2018","unstructured":"Pan J, et al. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Sci Rep. 2018;8:1117. https:\/\/doi.org\/10.1038\/s41598-018-19463-2.","journal-title":"Sci Rep"},{"key":"1692_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1208\/s12249-017-0833-y","volume":"19","author":"A Jose","year":"2018","unstructured":"Jose A, et al. Effective skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA using Cationic Liposomes. AAPS PharmSciTech. 2018;19:166\u201375. https:\/\/doi.org\/10.1208\/s12249-017-0833-y.","journal-title":"AAPS PharmSciTech"},{"key":"1692_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18632\/oncotarget.23989","volume":"9","author":"MC Sini","year":"2018","unstructured":"Sini MC, et al. Genetic alterations in main candidate genes during melanoma progression. Oncotarget. 2018;9:10.","journal-title":"Oncotarget"},{"key":"1692_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.biotechadv.2016.01.004","volume":"34","author":"AK Brys","year":"2016","unstructured":"Brys AK, et al. Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy. Biotechnol Adv. 2016;34:565\u201377. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.01.004.","journal-title":"Biotechnol Adv"},{"key":"1692_CR8","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.2174\/1381612824666180807120017","volume":"24","author":"J Rosa","year":"2018","unstructured":"Rosa J, et al. Current non-viral siRNA Delivery systems as a Promising treatment of skin diseases. Curr Pharm Des. 2018;24:2644\u201363. https:\/\/doi.org\/10.2174\/1381612824666180807120017.","journal-title":"Curr Pharm Des"},{"key":"1692_CR9","doi-asserted-by":"publisher","first-page":"115198","DOI":"10.1016\/j.addr.2024.115198","volume":"207","author":"AVP Silvestrini","year":"2024","unstructured":"Silvestrini AVP, et al. Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy. Adv Drug Deliv Rev. 2024;207:115198. https:\/\/doi.org\/10.1016\/j.addr.2024.115198.","journal-title":"Adv Drug Deliv Rev"},{"key":"1692_CR10","doi-asserted-by":"publisher","unstructured":"Viegas JSR, et al. Challenges to perform an efficient gene therapy adopting non-viral vectors: Melanoma landscape. J Drug Deliv Sci Technol. 2022;78. https:\/\/doi.org\/10.1016\/j.jddst.2022.103964.","DOI":"10.1016\/j.jddst.2022.103964"},{"key":"1692_CR11","doi-asserted-by":"publisher","first-page":"29159","DOI":"10.1038\/srep29159","volume":"6","author":"R Ruan","year":"2016","unstructured":"Ruan R, et al. Topical and targeted delivery of siRNAs to Melanoma cells using a Fusion peptide carrier. Sci Rep. 2016;6:29159. https:\/\/doi.org\/10.1038\/srep29159.","journal-title":"Sci Rep"},{"key":"1692_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2019.02.028","volume":"299","author":"J Frombach","year":"2019","unstructured":"Frombach J, et al. Core-multishell nanocarriers enhance drug penetration and reach keratinocytes and antigen-presenting cells in intact human skin. J Control Release. 2019;299:138\u201348. https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.028.","journal-title":"J Control Release"},{"key":"1692_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","volume":"361","author":"SH El Moukhtari","year":"2023","unstructured":"El Moukhtari SH, et al. Lipid nanoparticles for siRNA delivery in cancer treatment. J Control Release. 2023;361:130\u201346. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.054.","journal-title":"J Control Release"},{"key":"1692_CR14","doi-asserted-by":"publisher","unstructured":"de Araujo MM, et al. Solid lipid-polymer hybrid nanoplatform for topical delivery of siRNA: in Vitro Biological Activity and Permeation studies. J Funct Biomater. 2023;14. https:\/\/doi.org\/10.3390\/jfb14070374.","DOI":"10.3390\/jfb14070374"},{"key":"1692_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","volume":"10","author":"JSR Viegas","year":"2020","unstructured":"Viegas JSR, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-alpha siRNA as an innovative approach to psoriasis. Drug Deliv Transl Res. 2020;10:646\u201360. https:\/\/doi.org\/10.1007\/s13346-020-00723-6.","journal-title":"Drug Deliv Transl Res"},{"key":"1692_CR16","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666171122111132","author":"DH Shastri","year":"2017","unstructured":"Shastri DH. Effective delivery routes and strategies for solid lipid nanoparticles (Sln) and nanostructured lipid carriers (Nlc). Curr Pharm Des. 2017. https:\/\/doi.org\/10.2174\/1381612823666171122111132.","journal-title":"Curr Pharm Des"},{"key":"1692_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11095-017-2330-0","volume":"35","author":"LB Tofani","year":"2018","unstructured":"Tofani LB, et al. In Vitro TyRP-1 Knockdown based on siRNA carried by Liquid Crystalline nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo. Pharm Res. 2018;35:104. https:\/\/doi.org\/10.1007\/s11095-017-2330-0.","journal-title":"Pharm Res"},{"key":"1692_CR18","doi-asserted-by":"publisher","first-page":"123019","DOI":"10.1016\/j.ijpharm.2023.123019","volume":"640","author":"AVP Silvestrini","year":"2023","unstructured":"Silvestrini AVP, et al. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs. Int J Pharm. 2023;640:123019. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123019.","journal-title":"Int J Pharm"},{"key":"1692_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2016.10.100","volume":"482","author":"RL Schenk","year":"2017","unstructured":"Schenk RL, et al. BCL-2: Long and winding path from discovery to therapeutic target. Biochem Biophys Res Commun. 2017;482:459\u201369. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.100.","journal-title":"Biochem Biophys Res Commun"},{"key":"1692_CR20","doi-asserted-by":"publisher","first-page":"123889","DOI":"10.1016\/j.ijpharm.2024.123889","volume":"653","author":"S Samia","year":"2024","unstructured":"Samia S, et al. Recent trends and advances in novel formulations as an armament in Bcl-2\/Bax targeted breast cancer. Int J Pharm. 2024;653:123889. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123889.","journal-title":"Int J Pharm"},{"key":"1692_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, et al. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77:1745\u201370. https:\/\/doi.org\/10.1007\/s00018-019-03351-7.","journal-title":"Cell Mol Life Sci"},{"key":"1692_CR22","doi-asserted-by":"publisher","first-page":"111781","DOI":"10.1016\/j.msec.2020.111781","volume":"120","author":"ESM Cutrim","year":"2021","unstructured":"Cutrim ESM, et al. Preparation, characterization and in vitro anticancer performance of nanoconjugate based on carbon quantum dots and 5-Fluorouracil. Mater Sci Eng C Mater Biol Appl. 2021;120:111781. https:\/\/doi.org\/10.1016\/j.msec.2020.111781.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1692_CR23","doi-asserted-by":"publisher","first-page":"112043","DOI":"10.1016\/j.msec.2021.112043","volume":"124","author":"PS Mirzaghavami","year":"2021","unstructured":"Mirzaghavami PS, et al. Radio-sensitivity enhancement in HT29 cells through magnetic hyperthermia in combination with targeted nano-carrier of 5-Flourouracil. Mater Sci Eng C Mater Biol Appl. 2021;124:112043. https:\/\/doi.org\/10.1016\/j.msec.2021.112043.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1692_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/j.jid.2018.04.037","volume":"138","author":"A Nawaz","year":"2018","unstructured":"Nawaz A, Wong TW. Chitosan-Carboxymethyl-5-fluorouracil-folate conjugate particles: microwave modulated uptake by skin and Melanoma Cells. J Invest Dermatol. 2018;138:2412\u201322. https:\/\/doi.org\/10.1016\/j.jid.2018.04.037.","journal-title":"J Invest Dermatol"},{"key":"1692_CR25","doi-asserted-by":"publisher","unstructured":"Micali G, et al. Topical pharmacotherapy for skin cancer: part I. Pharmacology. J Am Acad Dermatol. 2014;70. https:\/\/doi.org\/10.1016\/j.jaad.2013.12.045. 965 e961-912; quiz 977\u2013\u2009968.","DOI":"10.1016\/j.jaad.2013.12.045"},{"key":"1692_CR26","doi-asserted-by":"publisher","first-page":"110245","DOI":"10.1016\/j.msec.2019.110245","volume":"106","author":"EY Hanurry","year":"2020","unstructured":"Hanurry EY, et al. In vitro siRNA delivery via diethylenetriamine- and tetraethylenepentamine-modified carboxyl group-terminated poly(amido)amine generation 4.5 dendrimers. Mater Sci Eng C Mater Biol Appl. 2020;106:110245. https:\/\/doi.org\/10.1016\/j.msec.2019.110245.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1692_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejps.2017.09.034","volume":"111","author":"FSG Praca","year":"2018","unstructured":"Praca FSG, et al. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. Eur J Pharm Sci. 2018;111:121\u201332. https:\/\/doi.org\/10.1016\/j.ejps.2017.09.034.","journal-title":"Eur J Pharm Sci"},{"key":"1692_CR28","doi-asserted-by":"publisher","first-page":"105769","DOI":"10.1016\/j.ejps.2021.105769","volume":"160","author":"MN Leite","year":"2021","unstructured":"Leite MN, et al. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug Dacarbazine. Eur J Pharm Sci. 2021;160:105769. https:\/\/doi.org\/10.1016\/j.ejps.2021.105769.","journal-title":"Eur J Pharm Sci"},{"key":"1692_CR29","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.bbrc.2017.06.166","volume":"490","author":"TAM Andrade","year":"2017","unstructured":"Andrade TAM, et al. Skin changes in streptozotocin-induced diabetic rats. Biochem Biophys Res Commun. 2017;490:1154\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.166.","journal-title":"Biochem Biophys Res Commun"},{"key":"1692_CR30","doi-asserted-by":"publisher","unstructured":"Hawthorne D, et al. Sustained and targeted delivery of hydrophilic drug compounds: a review of existing and novel technologies from bench to bedside. J Drug Deliv Sci Technol. 2022;78. https:\/\/doi.org\/10.1016\/j.jddst.2022.103936.","DOI":"10.1016\/j.jddst.2022.103936"},{"key":"1692_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fbioe.2020.00437","volume":"8","author":"Q Li","year":"2020","unstructured":"Li Q, et al. Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic molecules. Front Bioeng Biotechnol. 2020;8:437. https:\/\/doi.org\/10.3389\/fbioe.2020.00437.","journal-title":"Front Bioeng Biotechnol"},{"key":"1692_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2018.06.017","volume":"284","author":"Y Sato","year":"2018","unstructured":"Sato Y, et al. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA. J Control Release. 2018;284:179\u201387. https:\/\/doi.org\/10.1016\/j.jconrel.2018.06.017.","journal-title":"J Control Release"},{"key":"1692_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.proeng.2015.07.011","volume":"110","author":"TA Andrade","year":"2015","unstructured":"Andrade TA, et al. Ex vivo model of human skin (hOSEC) as alternative to animal use for Cosmetic tests. Procedia Eng. 2015;110:67\u201373. https:\/\/doi.org\/10.1016\/j.proeng.2015.07.011.","journal-title":"Procedia Eng"},{"key":"1692_CR34","doi-asserted-by":"publisher","first-page":"115841","DOI":"10.1016\/j.biopha.2023.115841","volume":"169","author":"J Viegas","year":"2023","unstructured":"Viegas J, et al. Characterization of a human lesioned-skin model to assess the influence of skin integrity on drug permeability. Biomed Pharmacother. 2023;169:115841. https:\/\/doi.org\/10.1016\/j.biopha.2023.115841.","journal-title":"Biomed Pharmacother"},{"key":"1692_CR35","doi-asserted-by":"publisher","unstructured":"Kishi P, Price CJ. Life-threatening reaction with topical 5-Fluorouracil. Drug Saf Case Rep. 2018;5. https:\/\/doi.org\/10.1007\/s40800-017-0068-6. 4.","DOI":"10.1007\/s40800-017-0068-6"},{"key":"1692_CR36","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1208\/s12249-015-0328-7","volume":"16","author":"TN Chinembiri","year":"2015","unstructured":"Chinembiri TN, et al. Topical delivery of 5-Fluorouracil from Pheroid formulations and the. Vitro Efficacy against Hum Melanoma AAPS PharmSciTech. 2015;16:1390\u20139. https:\/\/doi.org\/10.1208\/s12249-015-0328-7.","journal-title":"Vitro Efficacy against Hum Melanoma AAPS PharmSciTech"},{"key":"1692_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jconrel.2018.05.038","volume":"283","author":"R Petrilli","year":"2018","unstructured":"Petrilli R, et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. J Control Release. 2018;283:151\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.038.","journal-title":"J Control Release"},{"key":"1692_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2018.11.018","volume":"174","author":"P Sahu","year":"2019","unstructured":"Sahu P, et al. pH responsive 5-Fluorouracil loaded Biocompatible Nanogels for Topical Chemotherapy of Aggressive Melanoma. Colloids Surf B Biointerfaces. 2019;174:232\u201345. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.018.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1692_CR39","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","volume":"16","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Surface modification of lipid-based nanoparticles. ACS Nano. 2022;16:7168\u201396. https:\/\/doi.org\/10.1021\/acsnano.2c02347.","journal-title":"ACS Nano"},{"key":"1692_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.11.012","volume":"516","author":"MM El-Hammadi","year":"2017","unstructured":"El-Hammadi MM, et al. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. Int J Pharm. 2017;516:61\u201370. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.012.","journal-title":"Int J Pharm"},{"key":"1692_CR41","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.2147\/IJN.S117511","volume":"11","author":"PS Rajinikanth","year":"2016","unstructured":"Rajinikanth PS, Chellian J. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. Int J Nanomed. 2016;11:5067\u201377. https:\/\/doi.org\/10.2147\/IJN.S117511.","journal-title":"Int J Nanomed"},{"key":"1692_CR42","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ijpharm.2016.09.076","volume":"513","author":"MA Safwat","year":"2016","unstructured":"Safwat MA, et al. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells. Int J Pharm. 2016;513:648\u201358. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.076.","journal-title":"Int J Pharm"},{"key":"1692_CR43","doi-asserted-by":"publisher","unstructured":"Krivitsky A, et al. Molecular Weight-Dependent activity of Aminated Poly(alpha)glutamates as siRNA nanocarriers. Polym (Basel). 2018;10. https:\/\/doi.org\/10.3390\/polym10050548.","DOI":"10.3390\/polym10050548"},{"key":"1692_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/acsnano.7b05528","volume":"12","author":"DW Malcolm","year":"2018","unstructured":"Malcolm DW, et al. The effects of Biological fluids on Colloidal Stability and siRNA delivery of a pH-Responsive Micellar Nanoparticle Delivery System. ACS Nano. 2018;12:187\u201397. https:\/\/doi.org\/10.1021\/acsnano.7b05528.","journal-title":"ACS Nano"},{"key":"1692_CR45","doi-asserted-by":"publisher","unstructured":"Kulchar RJ, et al. Delivery of biologics: topical administration. Biomaterials. 2023;302. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122312.","DOI":"10.1016\/j.biomaterials.2023.122312"},{"key":"1692_CR46","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s13346-022-01267-7","volume":"13","author":"EV Louw","year":"2023","unstructured":"Louw EV, et al. Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension. Drug Deliv Transl Res. 2023;13:1372\u201389. https:\/\/doi.org\/10.1007\/s13346-022-01267-7.","journal-title":"Drug Deliv Transl Res"},{"key":"1692_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1524-4725.2007.33090.x","volume":"33","author":"K Gross","year":"2007","unstructured":"Gross K, et al. 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg. 2007;33:433\u20139. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33090.x. discussion 440.","journal-title":"Dermatol Surg"},{"key":"1692_CR48","doi-asserted-by":"publisher","first-page":"e2308217","DOI":"10.1002\/adma.202308217","volume":"36","author":"J Shao","year":"2024","unstructured":"Shao J, et al. Self-Heating Multistage Microneedle Patch for topical therapy of skin Cancer. Adv Mater. 2024;36:e2308217. https:\/\/doi.org\/10.1002\/adma.202308217.","journal-title":"Adv Mater"},{"key":"1692_CR49","doi-asserted-by":"publisher","unstructured":"Kim S, et al. Enhanced skin permeation of 5-Fluorouracil through drug-in-Adhesive Topical patches. Pharmaceutics. 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16030379.","DOI":"10.3390\/pharmaceutics16030379"},{"key":"1692_CR50","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3892\/or.2013.2539","volume":"30","author":"ZM Geng","year":"2013","unstructured":"Geng ZM, et al. Bcl-2 gene silencing by RNA interference inhibits the growth of the human gallbladder carcinoma cell line GBC-SD in vitro and in vivo. Oncol Rep. 2013;30:793\u2013800. https:\/\/doi.org\/10.3892\/or.2013.2539.","journal-title":"Oncol Rep"},{"key":"1692_CR51","doi-asserted-by":"publisher","first-page":"115295","DOI":"10.1016\/j.addr.2024.115295","volume":"208","author":"J Viegas","year":"2024","unstructured":"Viegas J, Sarmento B. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research. Adv Drug Deliv Rev. 2024;208:115295. https:\/\/doi.org\/10.1016\/j.addr.2024.115295.","journal-title":"Adv Drug Deliv Rev"},{"key":"1692_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jconrel.2024.02.011","volume":"368","author":"P Zarmpi","year":"2024","unstructured":"Zarmpi P, et al. Evaluation of chemical disposition in skin by stimulated Raman scattering microscopy. J Control Release. 2024;368:797\u2013807. https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.011.","journal-title":"J Control Release"}],"updated-by":[{"DOI":"10.1007\/s13346-024-01717-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000}}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01692-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01692-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T18:05:52Z","timestamp":1735495552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01692-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01692-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4356428\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"29 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13346-024-01717-4","URL":"https:\/\/doi.org\/10.1007\/s13346-024-01717-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol of Ex vivo - Human Organotypic Skin Explant Culture (hOSEC) (Sect.\u00a02.5.2) using human skin was approved by the Research Ethics Committee of Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Brazil (n\u00ba 12175\/2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for ex vivo studies"}}]}}